ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 44 filers reported holding ACORDA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $5,520,000,000 | +72.7% | 5,810,000 | 0.0% | 0.08% | +23.1% |
Q4 2020 | $3,196,000,000 | -26.6% | 5,810,000 | +9.4% | 0.06% | -41.4% |
Q3 2020 | $4,354,000,000 | -4.7% | 5,310,000 | 0.0% | 0.11% | +9.9% |
Q2 2020 | $4,567,000,000 | +33.5% | 5,310,000 | +32.8% | 0.10% | +44.3% |
Q1 2020 | $3,420,000,000 | -89.1% | 4,000,000 | -90.0% | 0.07% | -92.0% |
Q3 2019 | $31,402,000,000 | -8.8% | 40,000,000 | 0.0% | 0.87% | +31.0% |
Q2 2019 | $34,444,000,000 | +311.8% | 40,000,000 | +300.0% | 0.67% | +120.9% |
Q4 2018 | $8,365,000,000 | +881.8% | 10,000,000 | +900.0% | 0.30% | +1913.3% |
Q4 2017 | $852,000,000 | -6.2% | 1,000,000 | 0.0% | 0.02% | +15.4% |
Q3 2017 | $908,000,000 | +5.2% | 1,000,000 | 0.0% | 0.01% | -7.1% |
Q2 2017 | $863,000,000 | -49.1% | 1,000,000 | -50.0% | 0.01% | -51.7% |
Q1 2017 | $1,697,000,000 | -92.0% | 2,000,000 | -92.9% | 0.03% | -93.0% |
Q4 2016 | $21,345,000,000 | +47.5% | 28,000,000 | +57.7% | 0.41% | +91.6% |
Q3 2016 | $14,467,000,000 | – | 17,750,000 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LINDEN ADVISORS LP | 15,510,000 | $16,119,000 | 3.21% |
GRACE BROTHERS MANAGEMENT LLC | 2,500,000 | $2,592,000 | 2.44% |
Mohican Financial Management, LLC | 3,000,000 | $3,113,000 | 1.52% |
Wellesley Asset Management | 20,902 | $21,872,000 | 1.36% |
Fore Research & Management, LP | 31,595,000 | $32,937,000 | 0.97% |
Man Investments (CH) AG | 1,700,000 | $1,787,000 | 0.93% |
SYMPHONY ASSET MANAGEMENT LLC | 7,834,000 | $8,128,000 | 0.84% |
BASSO CAPITAL MANAGEMENT, L.P. | 5,000,000 | $5,150,000 | 0.79% |
Baker Brothers Advisors | 60,000,000 | $62,050,000 | 0.78% |
CAMDEN ASSET MANAGEMENT L P /CA | 10,225,000 | $10,608,000 | 0.44% |